Otitis Media With Effusion and Type 2 Inflammation Diseases
NCT ID: NCT06403319
Last Updated: 2024-05-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
100622 participants
OBSERVATIONAL
2009-01-01
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy and Cost Analysis of Steroids in Treatment of Otitis Media With Effusion
NCT03590912
A Study of the Clinicopathologic Behaviour of the Different Types of Unsafe Chronic Otitis Media
NCT00270660
Vaccination for Middle Ear Infection
NCT00001605
Coherent Optical Detection of Middle Ear Disease
NCT05353569
Does Tympanometry Predict Antibiotic Usage in Acute Otitis Media?
NCT01941381
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* At least two outpatient visits or one hospitalization record
* Medical records within the database
Exclusion Criteria
* Participants with unclear demographic information
* Participants with a history of ear surgery or congenital ear anomalies
* Participants who had undergone OME surgery before the index date
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hearing and Language Healthcare Center, China Medical University Hsinchu Hospital, Taiwan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OME-S-24-00723
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.